Accordingly, we found that a higher fraction of CD8+ T cells in NR patients are closer to TAMs and FoxP3+ cells, making us to assume that macrophages and Treg act as immunosuppressive populations limiting CTL anti-tumor activity and patient response to ONCOFID-P-BTM. Here, FOXP3 is linked to neoplasm.